Què significa "Esborrar"?
L'animal no porta la mutació. No desenvoluparà la malaltia i no ho transmetrà.
gos Gangliosidosi tipus 1 a Shiba Inu (GM1-SI)
Discover the importance of the DNA test for Gangliosidosis Type 1 (GM1) in Shiba Inu dogs, a critical genetic screening to ensure your pet’s health. GM1 gangliosidosis is a rare but severe inherited disorder affecting the nervous system, leading to progressive neurological decline. Early DNA testing helps breeders and owners identify carriers and affected dogs, preventing the spread of this debilitating condition. By using a reliable GM1 DNA test, you can make informed breeding decisions and protect future generations of Shiba Inu. Ensure your dog’s well-being with accurate genetic screening for Gangliosidosis Type 1 today. Prioritize health and longevity with this essential DNA test for Shiba Inu.
Abreviatura: GM1-SI
Mutació analitzada: GLB1 c.1649delC
Herència: Autosòmic recessiu
Acrònim
GM1-SI
Freqüència observada
Gravetat clínica
Classificació clínica
Malalties neurològiques
Mutació analitzada
GLB1 c.1649delC
p.(P550Rfs*50)
p.(P550Rfs*50)
Modalitat d'herència
Autosòmic recessiu (Complet)
Resum de la prova:
The DNA test for Gangliosidosis Type 1 (GM1) in Shiba Inu dogs helps identify carriers and affected individuals of this genetic disorder. GM1 gangliosidosis is a rare, inherited lysosomal storage disease that causes progressive neurological decline. Early detection through genetic testing allows breeders to make informed decisions to reduce the risk of passing the condition to offspring. This test is crucial for maintaining the health and longevity of the Shiba Inu breed. Responsible breeding practices rely on such DNA tests to prevent the spread of GM1 in the population.
Disponible des del pack: Basic
Aquesta prova d'ADN s'inclou a partir del nostre pack Basic — i també forma part dels packs Basic, Standard, Advanced, Complete.
Veure paquets de proves d'ADN →Tria el paquet que millor s'adapti a la teva estratègia de cria o salut dels teus animals.
Understanding Gangliosidosis Type 1 (GM1) in Shiba Inu
Gangliosidosis Type 1, commonly referred to as GM1, is a genetic disorder that affects the metabolism of certain lipids, specifically gangliosides, in the brain and nervous system of dogs. This condition is particularly noted in the Shiba Inu breed. GM1 is caused by a deficiency in the enzyme beta-galactosidase, which leads to the accumulation of gangliosides in the cells, resulting in neurological dysfunction and a range of clinical symptoms.
Clinical Symptoms of GM1
The symptoms of Gangliosidosis Type 1 typically manifest between the ages of three to six months. Affected dogs may exhibit a variety of neurological signs, including but not limited to, ataxia (loss of coordination), tremors, seizures, and a decline in cognitive functions. As the disease progresses, dogs may experience muscle weakness, difficulty walking, and a general decline in their quality of life. In severe cases, GM1 can lead to premature death, often occurring within the first few years of life.
Diagnosis of GM1
Diagnosis of Gangliosidosis Type 1 is primarily achieved through genetic testing that identifies mutations in the gene responsible for producing the beta-galactosidase enzyme. While clinical signs can suggest the presence of GM1, definitive diagnosis through a DNA test is crucial for confirming the disorder. Early detection allows for better management of the dog's health and can guide owners in making informed decisions about their pet's care.
Treatment and Management
Currently, there is no cure for Gangliosidosis Type 1, and treatment focuses on managing the symptoms and improving the quality of life for affected dogs. Supportive care may include physical therapy, pain management, and nutritional support. Regular veterinary check-ups are essential to monitor the progression of the disease and to address any arising complications.
Importància de les proves genètiques
Genetic testing for GM1 is critical for breeders and dog owners. By identifying carriers of the disease, responsible breeding practices can be implemented to reduce the incidence of GM1 in future generations. Awareness and understanding of this condition are vital in promoting the health and longevity of the Shiba Inu breed.
Raça reconeguda per a la prova: Gangliosidosi tipus 1 a Shiba Inu (GM1-SI)
- Shiba Inu
🧬 Interpretation of genotypes GM1-SI
Genotip
Estat
🟡 N/N
No transportista - Sense risc
🟡 N/GM1-SI
Transportista - Sense risc
❌ GM1-SI/GM1-SI
Afectat - En risc
Preguntes freqüents: entendre la interpretació
Un "Transportista" és seriós?
No. L'animal és generalment sa, però pot transmetre la mutació al seu descendència.
Què passa si un animal està "afectat"?
Porta dues còpies mutades. S'esperen signes clínics segons la malaltia. No s'ha de criar.
Per què hi ha diferències entre home/dona?
Algunes malalties estan lligades al sexe, de manera que la seva expressió varia en funció de la sexe de l'animal.
Prediu la descendència
N/N (no-transportista)
N/GM1-SI (Portador)
GM1-SI/GM1-SI (Afectat)
Preguntes freqüents sobre les proves d'ADN
Què detecta aquesta prova d'ADN?
This DNA test detects the mutation associated with Gangliosidosis Type 1 In Shiba Inu (GM1-SI) in order to identify clear, carrier, or at-risk animals.
Per què provar un animal reproductor?
Les proves d'ADN ajuden els criadors a planificar aparellaments més segurs i reduir el risc de transmetre la mutació a la descendència.
Quina és la manera d'herència d'aquesta prova?
El mode d'herència informat per a aquesta prova és autosòmic recessiu.
Quina mutació s'analitza en aquesta prova?
This test analyses the mutation GLB1 c.1649delC.
Un animal portador està necessàriament afectat?
No necessàriament. La interpretació depèn del patró d'herència i del genotip resultant.
Referències
Yamato O, Endoh D, Kobayashi A, Masuoka Y, Yonemura M, Hatakeyama A, Satoh H, Tajima M, Yamasaki M, Maede Y. A novel mutation in the gene for canine acid beta-galactosidase that causes GM1-gangliosidosis in Shiba dogs. J Inherit Metab Dis. 2002 Oct;25(6):525-6. doi: 10.1023/a:1021280007739.